StockData
CME Group Inc. logo

CME Group Inc. (CME) operating KPIs

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value
$303.14+6.72 (+2.27%)

Close on Oct 30, 2026Market cap $109.00BP/E 25.7Yield 1.65%

CME share repurchase program remaining dollar authorization ($M)

Form 10-Q / 10-K Note 15 & SEC XBRL

Latest, Q3 2026
1,000
Period ended Sep 30, 2026
Change on a year earlier
-66.7%
3,000 in Q3 2025
History
5 quarters
Since Q2 2025
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare repurchase program remaining dollar authorization ($M)Year on yearSource
Q3 2026Sep 30, 20261,000-66.7%CME Form 10-Q (2026-10-23) ↗
Q2 2026Jun 30, 20261,500-50.0%CME Form 10-Q (2026-07-24) ↗
Q1 2026Mar 31, 20262,200–CME Form 10-Q (2026-04-24) ↗
Q3 2025Sep 30, 20253,000–CME Form 10-Q (2026-10-23) ↗
Q2 2025Jun 30, 20253,000–CME Form 10-Q (2026-07-24) ↗

Breakdown

What makes up share repurchase program remaining dollar authorization

Cite this data

StockData. (2026). CME Share repurchase program remaining dollar authorization ($M), quarterly Q2 2025–Q3 2026 [Data set]. Compiled from CME SEC filings and investor materials. https://stockdatahq.com/stocks/cme/kpis/buyback-rem-auth

See every metric in the CME KPI table. Data updated Oct 28, 2026.